Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging-pathology study

M Buciuc1, J R Duffy1, M M Machulda2

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

Insights

Microbleeds and superficial siderosis in logopenic progressive aphasia strongly indicate cerebral amyloid angiopathy. Further research is needed to understand the topographic distribution of these neuroimaging findings.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Neurodegenerative diseases

Background:

  • Cerebral microbleeds (MB) and superficial siderosis (SS) are common in logopenic progressive aphasia (LPA).
  • Cerebral amyloid angiopathy (CAA) is suspected as the cause of MB/SS in LPA.
  • Limited neuroimaging-pathologic data exist for MB/SS in LPA.

Purpose of the Study:

  • To investigate the association between MB/SS and CAA in LPA patients.
  • To compare neuroimaging and pathologic characteristics in LPA patients with and without MB/SS.

Main Methods:

  • Included 13 LPA patients with antemortem diagnosis, MRI, and autopsy data.
  • Compared demographic, genetic, neuroimaging, clinical, and pathologic features.
  • Used Fisher exact and Wilcoxon rank sum tests for statistical analysis.

Main Results:

  • Six of 13 patients (46%) had MB/SS.
  • Moderate/severe CAA was significantly associated with MB/SS (p=0.029).
  • MB/SS predominantly affected frontal and parietal lobes.

Conclusions:

  • MB/SS presence is a strong indicator of moderate/severe CAA in LPA.
  • The topographic distribution of MB/SS in LPA remains unclear.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...